• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION NC EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION NC EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 7311
Device Problem Material Rupture (1546)
Patient Problems Hematoma (1884); Pericardial Effusion (3271)
Event Date 09/06/2021
Event Type  Injury  
Event Description
It was reported that balloon rupture, hematoma, and pericardial effusion occurred.The 70-80% stenosed target lesion was located in the left anterior descending artery (lad) before the first diagonal.A 3.00 x 12mm synergy xd was implanted and post dilated with a 3.50 x 8mm nc emerge at 14 atmospheres.Post stenting optical coherence tomography imaging showed the stent had proximal edge strut malapposition.The physician decided to post-dilate with a 3.5mm x 8mm nc emerge balloon catheter from 16-20 atmospheres.However, during inflation at 18 atmospheres, the balloon ruptured and was removed.The physician suspected there was a perforation but an angiogram revealed a large intramural hematoma from the proximal lad to the left main artery.They proceeded with an urgent echocardiogram which showed no pericardial effusion.After 20 minutes, a repeat catheterization and ivus showed hematoma.There is no dissection and the hematoma size had been reduced.A repeat echo showed effusion but the patient activated clotting time was normal (above 350).The physician send the patient for ct aortogram & observation.No further complications were reported and the patient was stable.
 
Event Description
It was reported that balloon rupture, hematoma, and pericardial effusion occurred.The 70-80% stenosed target lesion was located in the left anterior descending artery (lad) before the first diagonal.A 3.00 x 12mm synergy xd was implanted and post dilated with a 3.50 x 8mm nc emerge at 14 atmospheres.Post stenting optical coherence tomography imaging showed the stent had proximal edge strut malposition.The physician decided to post-dilate with a 3.5mm x 8mm nc emerge balloon catheter from 16-20 atmospheres.However, during inflation at 18 atmospheres, the balloon ruptured and was removed.The physician suspected there was a perforation but an angiogram revealed a large intramural hematoma from the proximal lad to the left main artery.They proceeded with an urgent echocardiogram which showed no pericardial effusion.After 20 minutes, a repeat catheterization and ivus showed hematoma.There is no dissection and the hematoma size had been reduced.A repeat echo showed effusion but the patient activated clotting time was normal (above 350).The physician send the patient for ct aortogram & observation.No further complications were reported and the patient was stable.
 
Manufacturer Narrative
Returned product consisted of an nc emerge balloon catheter.The shaft, hypotube, tip and balloon were microscopically and visually examined.There were numerous kinks.There was contrast and blood in the inflation lumen and balloon.The balloon was loosely folded.Microscopic inspection revealed tip damage.The device was prepped with an inflation device filled with water and connected to the inflation port to inflate the device.There was a pinhole at the proximal marker band.There was no marker band damage detected.Inspection of the remainder of the device presented no other damage or irregularities.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NC EMERGE
Type of Device
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key12490363
MDR Text Key271986463
Report Number2134265-2021-11683
Device Sequence Number1
Product Code LOX
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/28/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/17/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/23/2023
Device Model Number7311
Device Catalogue Number7311
Device Lot Number0027016551
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/12/2021
Date Manufacturer Received10/27/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-